MarketWatch
US · 9 mins ago
Moderna’s experimental vaccine prevents cancer recurrence, in ‘historic’ win for personalized medicine. Its stock soared.
The candidate is a combination of an mRNA therapeutic vaccine and Merck’s cancer drug Keytruda.
Do you trust MarketWatch?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!